For Immediate Release
Chicago, IL – March 8, 2010 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Lions Gate Entertainment (LGF), Motorola (MOT), Yahoo! (YHOO), Walt Disney (DIS) and Allscripts-Misys Healthcare Solutions Inc. (MDRX).
Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513
Here are highlights from Friday’s Analyst Blog:
Carl Icahn: A Lion at the Gate?
With the Oscars coming up this Sunday, Icahn seems an interesting topic for the investor looking for new ideas. He is currently attempting to increase his share of Lions Gate Entertainment (LGF), a publicly traded production and distribution company with more than 500 titles to its credit, from 18.9% to 29.9%. Along with this, Icahn wants a lot more say in the way Lions Gate is run.
Ask any long-term investor of Motorola (MOT) or Yahoo! (YHOO) what Icahn’s involvement may mean. The man has been as dramatic a part in those companies’ fortunes as Marlon Brando has been in any of his films.
Lions Gate has been publicly traded since the late 1990s, and currently distributes the Oscar-nominated feature film “Precious,” which is up for Best Picture, Best Supporting Actress and four other major Academy Awards on Sunday. Lions Gate was also the distributor for Best Picture winner “Crash” in 2005, but the company may be best known for its involvement in the phenomenal success of 1999’s “The Blair Witch Project” — a film that cost $60,000 to make and brought in $141 million in U.S. box office.
According to the L.A. Times, Carl Icahn believes Lions Gate is wrongheaded in its interests to purchase struggling competitor Metro-Goldwyn-Mayer or Miramax, which is currently owned by The Walt Disney Company (DIS). And say what you want about Icahn the man, he knows enough not to pay too much for something he’s interested in.
That said, Lions Gate Films is currently rated a Zacks #5 Rank (Strong Sell). Clearly, Carl Icahn may have the stomach for a prolonged battle — like a 3 1/2-hour Akira Kurosawa film — but analysts, 7 of whom have downwardly revised estimates for 4th quarter 2010 (ending March 31) and 9 who have lowered estimates for the year, apparently feel differently. Perhaps activist investing, like gruesome horror flicks, is not for the faint of heart.
New Clients for Allscripts
Allscripts-Misys Healthcare Solutions Inc. (MDRX) has recently entered into an agreement with two new clients, Covenant Health and Sharp HealthCare.
These two clients have selected the Allscripts Care Management and Post Acute solutions to automate administrative processes in their hospitals and post-acute care facilities, improve efficiency, streamline and enhance the quality of patient care, and generate cost savings.
Allscripts Care Management solution is a fully integrated, Software-as-a-Service (SaaS) application that automates and consolidates everyday tasks for hospital case managers including utilization management, documentation integrity, discharge planning, audit and quality management.
Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=5515.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks “Profit from the Pros” e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=5517
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it’s your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=5518.
Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
Contact:
Mark Vickery
Web Content Editor
312-265-9380
Visit: www.zacks.com
